Marine-Derived Biomaterials for Bone Health
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Biomaterials of Marine Origin".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 7
Special Issue Editors
Interests: chitosan-based biomaterials; dental/craniofacial and orthopedic biomaterials; wound healing; tissue engineering/regenerative medicine
Special Issues, Collections and Topics in MDPI journals
Interests: regenerative medicine; musculoskeletal tissue engineering, vascularization, enabling technologies; engineering tools for tissue engineering, medical devices, regulatory and sterilization considerations
2. Hansjörg Wyss Department of Plastic Surgery-NYU Grossman School of Medicine, New York, NY 10010, USA
3. Department of Biomedical Engineering-NYU Tandon School of Engineering, Brooklyn, NY 10010, USA
Interests: biomaterials; bioengineering; additive manufacturing (3D printing)
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Bone fractures, defects and disorders and the need for reparative and/or regenerative therapies are significant global health concerns. While current standards of care such as autografts and allografts are effective, they have significant and well-documented drawbacks. Hence, clinically effective bone repair and regenerative therapies remain a major global healthcare challenge.
The ocean is a vast and largely untapped resource for next-generation biomaterials. Biomaterials derived from marine organisms such as collagen, chitosan, alginate, hydroxyapatite and bioactive compounds from algae, corals and crustaceans offer special advantages for bone repair, bone tissue engineering and regenerative medicine due to their biocompatibility, bioactivity, biomimetic structures and sustainable sourcing. Thus, they offer a promising strategy for overcoming the limitations of current bone healing treatments and grafts, leading to improved clinical therapies, patient outcomes and reduced healthcare costs.
The focus of this Special Issue will be on emerging opportunities and innovations in marine-derived biomaterials and compounds that address topics covering, but not limited to, the following: cost-effective and scalable production of marine biomaterials and products; novel physical–chemical modifications/compositions, functional scaffolds/templates with balanced mechanical, osteo-conductive/inductive and or angiogenic properties for load bearing applications; 3D architectures for bone ligament, cartilage, and muscle regeneration; anti-infective biomaterials; and immune-modulation, anti-cancer, and clinical translation and regulatory pathways. We welcome original research articles, comprehensive reviews, and opinion articles from academic, clinical, and industry scientists and engineers.
Prof. Dr. Joel D. Bumgardner
Prof. Dr. Teja Guda
Dr. Lukasz Witek
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bone biomaterials
- bone tissue engineering
- bone tissue regeneration
- marine biomaterials
- 3d printing for bone
- bone bioprinting
- blue technology
- anti-osteosarcoma
- drug delivery
- regulatory pathways/considerations
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
